Akoya Biosciences Stock Probability of Future Stock Price Finishing Under 2.71
| AKYA Stock | USD 2.71 0.01 0.37% |
Closest to current price Akoya long CALL Option Payoff at Expiration
Akoya |
Akoya Biosciences Target Price Odds to finish below 2.71
The tendency of Akoya Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 2.71 | 90 days | 2.71 | about 87.76 |
Based on a normal probability distribution, the odds of Akoya Biosciences to move below current price in 90 days from now is about 87.76 (This Akoya Biosciences probability density function shows the probability of Akoya Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.55 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Akoya Biosciences will likely underperform. Additionally Akoya Biosciences has an alpha of 0.046, implying that it can generate a 0.046 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Akoya Biosciences Price Density |
| Price |
Predictive Modules for Akoya Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Akoya Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Akoya Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Akoya Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Akoya Biosciences is not an exception. The market had few large corrections towards the Akoya Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Akoya Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Akoya Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.05 | |
β | Beta against Dow Jones | 2.55 | |
σ | Overall volatility | 0.24 | |
Ir | Information ratio | 0.04 |
Akoya Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Akoya Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Akoya Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Akoya Biosciences had very high historical volatility over the last 90 days | |
| Akoya Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 96.63 M. Net Loss for the year was (63.32 M) with profit before overhead, payroll, taxes, and interest of 43.39 M. | |
| Akoya Biosciences currently holds about 87.61 M in cash with (50.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.31. | |
| Akoya Biosciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 67.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from MacroaxisInsider: Acquisition by Niro Ramachandran of 45000 shares of Akoya Biosciences at 12.3 subject to Rule 16b-3 |
Akoya Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Akoya Stock often depends not only on the future outlook of the current and potential Akoya Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Akoya Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44.4 M | |
| Cash And Short Term Investments | 83.1 M |
Akoya Biosciences Technical Analysis
Akoya Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Akoya Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Akoya Biosciences. In general, you should focus on analyzing Akoya Stock price patterns and their correlations with different microeconomic environments and drivers.
Akoya Biosciences Predictive Forecast Models
Akoya Biosciences' time-series forecasting models is one of many Akoya Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Akoya Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Akoya Biosciences
Checking the ongoing alerts about Akoya Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Akoya Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Akoya Biosciences had very high historical volatility over the last 90 days | |
| Akoya Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 96.63 M. Net Loss for the year was (63.32 M) with profit before overhead, payroll, taxes, and interest of 43.39 M. | |
| Akoya Biosciences currently holds about 87.61 M in cash with (50.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.31. | |
| Akoya Biosciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 67.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from MacroaxisInsider: Acquisition by Niro Ramachandran of 45000 shares of Akoya Biosciences at 12.3 subject to Rule 16b-3 |
Additional Information and Resources on Investing in Akoya Stock
When determining whether Akoya Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akoya Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akoya Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akoya Biosciences Stock:Check out Akoya Biosciences Backtesting, Akoya Biosciences Valuation, Akoya Biosciences Correlation, Akoya Biosciences Hype Analysis, Akoya Biosciences Volatility, Akoya Biosciences History as well as Akoya Biosciences Performance. For information on how to trade Akoya Stock refer to our How to Trade Akoya Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akoya Biosciences. If investors know Akoya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akoya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Revenue Per Share 1.889 | Quarterly Revenue Growth (0.01) | Return On Assets (0.18) | Return On Equity (1.28) |
The market value of Akoya Biosciences is measured differently than its book value, which is the value of Akoya that is recorded on the company's balance sheet. Investors also form their own opinion of Akoya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Akoya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akoya Biosciences' market value can be influenced by many factors that don't directly affect Akoya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akoya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akoya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akoya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.